Treatment of Benign Paroxysmal Positional Vertigo: An Approach Considering Patients’ Convenience

Shim, Dae Bo

doi:10.21053/ceo.2020.02082

Cited by 3 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Benign paroxysmal positional vertigo (BPPV) is a peripheral vestibular disorder with vertigo triggered by specific head positional changes [ 9 , 10 , 11 ]. BPPV is a common peripheral vestibular disorder whose prevalence is predicted to be approximately 2.4% [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

Association between Benign Paroxysmal Positional Vertigo and Previous Proton Pump Inhibitor Use: A Nested Case–Control Study Using a National Health Screening Cohort

Kim

Yoo

Kwon

et al. 2022

IJERPH

View full text Add to dashboard Cite

The present nested case–control study evaluated the impact of previous proton pump inhibitor (PPI) prescription on the risk of benign paroxysmal positional vertigo (BPPV). A ≥40-year-old Korean population was included. A total of 34,441 patients with BPPV was matched with 137,764 comparison participants for demographic and socioeconomic factors. Previous histories of PPI use and PPI prescription dates were compared between the BPPV and comparison groups. The odds ratios (ORs) with 95% confidence intervals (CIs) of PPI use for BPPV were calculated using a logistic regression. The demographic and socioeconomic factors and comorbidities were adjusted in the adjusted model. Both current and past PPI users were associated with higher odds for BPPV than non-PPI users (adjusted OR (aOR) = 3.57, 95% CI = 3.33–3.83, and p < 0.001 for current PPI users and aOR = 1.76, 95% CI = 1.64–1.89, and p < 0.001 for past PPI users). In addition, longer dates of PPI use were related to higher odds for BPPV (aOR (95% CI) = 1.95 [1.81–2.10] for ≥1 day and <30 days of PPI prescription, <2.88 [2.68–3.10] for ≥30 days and <365 days of PPI prescription, and <3.45 [3.19–3.73] for ≥365 days of PPI prescription). PPI use was linked with an elevated risk of BPPV in the adult population. The odds for BPPV were higher in patients with a longer duration of PPI use.

show abstract

Section: Introductionmentioning

confidence: 99%

Association between Benign Paroxysmal Positional Vertigo and Previous Proton Pump Inhibitor Use: A Nested Case–Control Study Using a National Health Screening Cohort

Kim

Yoo

Kwon

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…Benign paroxysmal positional vertigo (BPPV) is the most common cause of vestibular vertigo in elderly individuals [ 6 ]; approximately 30% of individuals aged ≥70 years report an episode of BPPV at least once in their lifetime [ 7 , 8 ]. Moreover, the response to canalith repositioning therapy tends to be lower and the rate of recurrent BPPV is higher in elderly patients than in younger individuals [ 6 , 9 , 10 ].…”

Section: Introductionmentioning

confidence: 99%

Increased Risk of Neurodegenerative Dementia after Benign Paroxysmal Positional Vertigo

Kim

Yoo

Min

et al. 2021

IJERPH

View full text Add to dashboard Cite

The aim of the present study was to estimate the risk of dementia in patients with benign paroxysmal positional vertigo (BPPV), using a population cohort. Data from the Korean National Health Insurance Service-National Sample Cohort for the population ≥ 60 years of age from 2002 to 2013 were collected. A total of 11,432 individuals with dementia were matched for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia with 45,728 individuals comprising the control group. The crude (simple) and adjusted odds ratios (ORs) of dementia in BPPV patients were analyzed using non-conditional logistic regression analyses. Subgroup analyses were conducted according to age and sex. A history of BPPV characterized 5.3% (609/11,432) of the dementia group and 2.6% (1,194/45,728) of the control group (P < 0.001). The adjusted OR of dementia for BPPV was 1.14 (95% CI = 1.03–1.26, P = 0.009). In subgroup analyses according to age and sex, males had higher ORs of dementia for BPPV. BPPV increases the risk of dementia in the 60 years of age or older population.

show abstract

Serum Estradiol Correlates With Benign Paroxysmal Positional Vertigo in Postmenopausal Women

Qian

Wang

2022

Endocrine Practice

View full text Add to dashboard Cite

Treatment of Benign Paroxysmal Positional Vertigo: An Approach Considering Patients’ Convenience

Cited by 3 publications

References 8 publications

Association between Benign Paroxysmal Positional Vertigo and Previous Proton Pump Inhibitor Use: A Nested Case–Control Study Using a National Health Screening Cohort

Association between Benign Paroxysmal Positional Vertigo and Previous Proton Pump Inhibitor Use: A Nested Case–Control Study Using a National Health Screening Cohort

Increased Risk of Neurodegenerative Dementia after Benign Paroxysmal Positional Vertigo

Serum Estradiol Correlates With Benign Paroxysmal Positional Vertigo in Postmenopausal Women

Contact Info

Product

Resources

About